Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05667519 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation (PLACE)

Study acronym: PLACE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
LMU Klinikum
20 trials monitored
See all monitored trials
Heart Disease
8,786 trials monitored
See 412 trials at risk
This is the first randomized controlled trial comparing transesophageal echocardiography + fluoroscopy guided lead implantation vs. standard lead implantation guided by fluoroscopy only. Patients are randomized 1:1 in the two groups and followed up for up to 3 years.
Trial Details
NCT Number NCT05667519
Lead Sponsor LMU Klinikum
Conditions
(from sponsor)		 Tricuspid Regurgitation, Pacemaker Complication
Related terms Tricuspid Valve Insufficiency
Enrollment 324 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov